How a massive European study provided crucial safety data for rheumatoid arthritis patients taking abatacept through real-world evidence analysis.
Explore how short-term tocilizumab treatment offers new hope for patients with active, moderate-to-severe rheumatoid arthritis through targeted IL-6 inhibition.
Exploring the compelling link between Proteus mirabilis bacteria and rheumatoid arthritis development through molecular mimicry mechanisms.
Exploring the complex relationship between rheumatoid arthritis and comorbid infections, including immune mechanisms, treatment dilemmas, and future research directions.
Discover how anti-carbamylated protein antibodies are solving the diagnostic dilemma of distinguishing rheumatoid arthritis from hepatitis C-induced arthropathy.
Exploring the link between anti-TNF therapy for rheumatoid arthritis and increased risk of septic arthritis based on the British Society for Rheumatology Biologics Register study.
Exploring the complex interaction between genetics and environmental factors in rheumatoid arthritis development, including new research on protective autoantibodies.
Exploring sustained remission with rituximab and etanercept combination therapy after TNF failure in rheumatoid arthritis through clinical case studies and scientific mechanisms.